Literature DB >> 17144670

Fungal heme oxygenases: Functional expression and characterization of Hmx1 from Saccharomyces cerevisiae and CaHmx1 from Candida albicans.

Donghak Kim1, Erik T Yukl, Pierre Moënne-Loccoz, Paul R Ortiz de Montellano.   

Abstract

Heme oxygenases convert heme to free iron, CO, and biliverdin. Saccharomyces cerevisiae and Candida albicans express putative heme oxygenases that are required for the acquisition of iron from heme, a critical process for fungal survival and virulence. The putative heme oxygenases Hmx1 and CaHmx1 from S. cerevisiae and C. albicans, respectively, minus the sequences coding for C-terminal membrane-binding domains, have been expressed in Escherichia coli. The C-terminal His-tagged, truncated enzymes are obtained as soluble, active proteins. Purified ferric Hmx1 and CaHmx1 have Soret absorption maxima at 404 and 410 nm, respectively. The apparent heme binding Kd values for Hmx1 and CaHmx1 are 0.34 +/- 0.09 microM and 1.0 +/- 0.2 microM, respectively. The resonance Raman spectra of Hmx1 reveal a heme binding pocket similar to those of the mammalian and bacterial heme oxygenases. Several reductants, including ascorbate, yeast cytochrome P450 reductase (CPR), human CPR, spinach ferredoxin/ferredoxin reductase, and putidaredoxin/putidaredoxin reductase, are able to provide electrons for biliverdin production by Hmx1 and CaHmx1. Of these, ascorbate is the most effective reducing partner. Heme oxidation by Hmx1 and CaHmx1 regiospecifically produces biliverdin IXalpha. Spectroscopic analysis of aerobic reactions with H2O2 identifies verdoheme as a reaction intermediate. Hmx1 and CaHmx1 are the first fungal heme oxygenases to be heterologously overexpressed and characterized. Their heme degradation activity is consistent with a role in iron acquisition.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17144670     DOI: 10.1021/bi061429r

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  24 in total

Review 1.  Response to iron deprivation in Saccharomyces cerevisiae.

Authors:  Caroline C Philpott; Olga Protchenko
Journal:  Eukaryot Cell       Date:  2007-11-09

2.  The fungal phytochrome FphA from Aspergillus nidulans.

Authors:  Sonja Brandt; David von Stetten; Mina Günther; Peter Hildebrandt; Nicole Frankenberg-Dinkel
Journal:  J Biol Chem       Date:  2008-10-19       Impact factor: 5.157

Review 3.  One ring to rule them all: trafficking of heme and heme synthesis intermediates in the metazoans.

Authors:  Iqbal Hamza; Harry A Dailey
Journal:  Biochim Biophys Acta       Date:  2012-05-08

Review 4.  Candida albicans cell wall proteins.

Authors:  W LaJean Chaffin
Journal:  Microbiol Mol Biol Rev       Date:  2008-09       Impact factor: 11.056

5.  A comprehensive mechanistic model of iron metabolism in Saccharomyces cerevisiae.

Authors:  Paul A Lindahl
Journal:  Metallomics       Date:  2019-09-18       Impact factor: 4.526

Review 6.  Heme Oxygenases in Cardiovascular Health and Disease.

Authors:  Anita Ayer; Abolfazl Zarjou; Anupam Agarwal; Roland Stocker
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

7.  Efficient catalytic turnover of cytochrome P450(cam) is supported by a T252N mutation.

Authors:  Donghak Kim; Yong-Seok Heo; Paul R Ortiz de Montellano
Journal:  Arch Biochem Biophys       Date:  2008-03-10       Impact factor: 4.013

8.  In-Cell Enzymology To Probe His-Heme Ligation in Heme Oxygenase Catalysis.

Authors:  Paul A Sigala; Koldo Morante; Kouhei Tsumoto; Jose M M Caaveiro; Daniel E Goldberg
Journal:  Biochemistry       Date:  2016-08-15       Impact factor: 3.162

9.  Limited role for the bilirubin-biliverdin redox amplification cycle in the cellular antioxidant protection by biliverdin reductase.

Authors:  Ghassan J Maghzal; Meng-Choo Leck; Emma Collinson; Cheng Li; Roland Stocker
Journal:  J Biol Chem       Date:  2009-08-18       Impact factor: 5.157

10.  Isocyanides inhibit human heme oxygenases at the verdoheme stage.

Authors:  John P Evans; Sylvie Kandel; Paul R Ortiz de Montellano
Journal:  Biochemistry       Date:  2009-09-22       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.